Clinical Trial

Study of Cognitive-Linguistic Profiles: The Role of Executive Control in Aphasia

Study acronym: P-CLAC
Not Yet Recruiting
View on ClinicalTrials.gov →
Summary
In France, stroke affects 150,000 people annually and is the leading cause of acquired disability in adults; 10-12% of patients exhibit mild post-stroke aphasia, a condition defined by language difficulties. Few studies describe mild post-stroke aphasia, and none characterize the impairment of linguistic executive control in this population; consequently, its prevalence remains unknown. To date, the role of linguistic executive control in mild aphasia remains an open question. The aim of this project is to investigate linguistic executive control impairment in stroke survivors with mild aphasia, provide an initial estimate of its prevalence, and demonstrate its interactions with other linguistic and communicative aspects, as well as with executive and attentional functions.
Trial Details
NCT Number NCT07766356
Lead Sponsor University Hospital, Toulouse
Conditions Stroke
Enrollment 30 participants
Start Date 2026-09-01
Primary Completion 2028-09-01 (estimated)
Study Completion 2028-09-08 (estimated)
Updated on ClinicalTrials.gov 2026-08-14